In this observation, quantitative analysis of fluorescence intensity showed that compared with the diabetes group, the average optical density of GSDMD in the SCU treatment group tended to decrease, supporting caspase-1 regulating GSDMD pathway has been involved in our observation. The gene discussed is CASP1; the disease is diabetes mellitus.